Table 3 Association between TFQIFT3 and PTFQIFT3 with CTM risk.

From: Chronic thyrotoxic myopathy development is associated with thyroid hormone sensitivity index, predicted by lower-limb fatigue and the squat-up test

 

Model 1

Model 2

Model 3

OR

95% CI

OR

95% CI

OR

95% CI

TFQIFT3

3.94

1.40-11.09*

4.35

1.46–13.01*

2.39

0.68–8.63

TFQIFT3  (quartile)

Q1

Ref

 

Ref

 

Ref

 

Q2

2.53

1.02–6.30*

2.59

1.03–6.52*

1.98

0.64–6.09

Q3

3.77

1.50–9.47*

4.06

1.57–10.52*

3.37

1.05–10.80*

Q4

3.41

1.36–8.52*

3.81

1.45–10.01*

2.54

0.81–7.92

P for trend

3.95

1.36–11.47*

4.57

1.46–14.28*

2.85

0.76–10.71

Per SD increase

1.53

1.11–2.10*

1.57

1.12–2.21*

1.31

0.88–1.93

PFTQIFT3

3.54

1.29–9.69

3.83

1.33–11.05*

2.22

0.68–7.52

PTFQI (quartile)

Q1

Ref

 

Ref

 

Ref

 

Q2

2.41

0.97–5.97*

2.50

0.99–6.25

1.93

0.63–5.88

Q3

4.48

1.76–11.43*

4.89

1.84–12.97*

4.00

1.21–13.15*

Q4

3.08

1.24–7.69*

3.42

1.31–8.92*

2.32

0.74–7.26

P for trend

9.03

1.62–50.30*

9.20

1.59–52.96*

8.59

0.98–74.99

Per SD increase

1.49

1.08–2.06*

1.53

1.09–2.15*

1.29

0.87–1.90

  1. CTM, chronic thyrotoxic myopathy; TFQIFT3, thyroid feedback quantile-based index calculated by free triiodothyronine; PTFQIFT3, parametric thyroid feedback quantile-based index calculated by free triiodothyronine; OR, odd ratio; CI, confidence interval.
Back to article page